← Back to headlines
Journey Medical Signals Positive EBITDA for 2026, Plans Sales Team Expansion
Journey Medical anticipates achieving positive EBITDA for the remainder of 2026 and plans to expand its sales team by up to five professionals.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
